Morning Business Report: New cancer treatment cures 14 patients in experimental trial

New data on a breast cancer treatment from AstraZeneca and Japanese drug maker Daiichi Sankyo brought a standing ovation in their annual meeting in Chicago. The drug, Enhertu, enabled women to live six months longer than other conventional means of Chemotherapy.

Evidence suggests this drug could be used to treat other types of tumors, after six months of experimental treatment, tumors vanished in all 14 patients diagnosed with early stage rectal cancer.

This experimental therapy was so successful none of the 14 patients who completed the trial had any follow-up appointments.